The impact of KEAP1 mutations on the TME is profound and highly significant, influencing various immune and metabolic pathways.
← all excerpts
Emerging insights into <i>STK11</i>, <i>KEAP1</i> and <i>KRAS</i> mutations: implications for immunotherapy in patients with advanced non-small cell lung cancer.
1
—
—